Dr Bastiaan Hoogendoorn
BSc, MSc, PhD, FHEA
Timau a rolau for Bastiaan Hoogendoorn
Darlithydd er Anrhydedd
Trosolwyg
Mae Dr Hoogendoorn yn Ddarlithydd yn y Ganolfan Addysg Feddygol yn yr Ysgol Feddygaeth. Dr Hoogendoorn yw'r 'Argyfwng, Cyn-ysbyty a Gofal Uniongyrchol' Intercalated BSc Dirprwy Gyfarwyddwr Rhaglen ac arweinydd modiwl ymchwil.
Cyhoeddiad
2016
- Clark, J. et al. 2016. The biological effects upon the cardiovascular system consequent to exposure to particulates of less than 500 nm in size. Biomarkers 21 (1), pp.1-47. (10.3109/1354750X.2015.1118540)
2013
- Elvidge, T. et al. 2013. Feasibility of using biomarkers in blood serum as markers of effect following exposure of the lungs to particulate matter air pollution [review]. Journal of Environmental Science and Health, Part C 31 (1), pp.1-44. (10.1080/10590501.2013.763575)
- Matthews, I. P. et al. 2013. Maximal extent of translocation of single-walled carbon nanotubes from lung airways of the rat. Environmental Toxicology and Pharmacology 35 (3), pp.461-464. (10.1016/j.etap.2013.02.002)
- Van Woerden, H. C. et al. 2013. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infectious Diseases 13 69. (10.1186/1471-2334-13-69)
2012
- Deschepper, M. P. et al. 2012. Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes. Brain Research Bulletin 88 (2-3), pp.210-222. (10.1016/j.brainresbull.2011.01.012)
- Hoogendoorn, B. et al. 2012. Gene and protein responses of human lung tissue explants exposed to ambient particulate matter of different sizes. Inhalation Toxicology 24 (14), pp.966-975. (10.3109/08958378.2012.742600)
2010
- Price, H. D. et al. 2010. Airborne particles in Swansea, UK: their collection and characterization. Journal of Toxicology and Environmental Health-Part A 73 (5-6), pp.355-367. (10.1080/15287390903442652)
2005
- Buckland, P. R. et al. 2005. Strong bias in the location of functional promoter polymorphisms. Human Mutation 26 (3), pp.214-223. (10.1002/humu.20207)
- Buckland, P. R. et al. 2005. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain. American Journal of Psychiatry 162 (3), pp.613-615. (10.1176/appi.ajp.162.3.613)
2004
- Buckland, P. R. et al. 2004. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Acta Biochimica et Biophysica 1690 (3), pp.238-249.
- Hoogendoorn, B. et al. 2004. Functional analysis of polymorphisms in the promoter regions of genes on 22q11. Human Mutation 24 (1), pp.35-42. (10.1002/humu.20061)
- Guy, C. et al. 2004. Promoter polymorphisms in glutathione-S-transferase genes affect transcription. Pharmacogenetics 14 (1), pp.45-51. (10.1097/00008571-200401000-00005)
2003
- Hoogendoorn, B. et al. 2003. Functional analysis of human promoter polymorphisms. Human Molecular Genetics 12 (18), pp.2249-2254. (10.1093/hmg/ddg246)
- Buckland, P. R. et al. 2003. A high proportion of chromosome 21 promoter polymorphisms influence transcriptional activity. Gene Expression 11 (5), pp.233-239. (10.3727/000000003783992225)
- Smith, S. K. et al. 2003. Lack of functional promoter polymorphisms in genes involved in glutamate neurotransmission. Psychiatric Genetics 13 (4), pp.193-199. (10.1097/00041444-200312000-00001)
2002
- Norton, N. et al., 2002. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Human Genetics 110 (5), pp.471-478. (10.1007/s00439-002-0706-6)
- Anney, R. et al. 2002. Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia. Molecular psychiatry 7 (5), pp.493-502. (10.1038/sj.mp.4001003)
- Coleman, S. L. et al. 2002. Experimental analysis of the annotation of promoters in the public database. Human Molecular Genetics 11 (16), pp.1817-1821. (10.1093/hmg/11.16.1817)
- Williams, N. M. et al. 2002. Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Molecular Psychiatry 7 (5), pp.508-514. (10.1038/sj.mp.4001030)
- Coleman, S. L. et al. 2002. Streamlined approach to functional analysis of promoter-region polymorphisms. Biotechniques 33 (2), pp.412-418.
2001
- Abraham, R. et al., 2001. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Human Genetics 109 (6), pp.646-652. (10.1007/s00439-001-0614-1)
- Bowen, T. et al. 2001. Mutation screening of the KCNN3 gene reveals a rare frameshift mutation [Letter]. Molecular Psychiatry 6 (3), pp.259-260. (10.1038/sj.mp.4000128)
2000
- Austin, J. et al., 2000. The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia. Molecular Psychiatry 5 (5), pp.552-557. (10.1038/sj.mp.4000761)
- Austin, J. et al., 2000. Association analysis of the proneurotensin gene and bipolar disorder. Psychiatric Genetics 10 (1), pp.51-54. (10.1097/00041444-200010010-00009)
- Austin, J. et al., 2000. Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Molecular Psychiatry 5 (2), pp.208-212. (10.1038/sj.mp.4000693)
- Hoogendoorn, B. et al. 2000. Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Human Genetics 107 (5), pp.488-493. (10.1007/s004390000397)
- Jones, A. C. et al., 2000. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Human Genetics 106 (6), pp.663-668. (10.1007/s004390000316)
- Speight, G. et al., 2000. Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Molecular Psychiatry 5 (3), pp.327-331. (10.1038/sj.mp.4000717)
1999
- Hoogendoorn, B. et al. 1999. Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Human Genetics 104 (1), pp.89-93. (10.1007/s004390050915)
- Jacobsen, N. J. et al., 1999. ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes. Human Molecular Genetics 8 (9), pp.1631-1636. (10.1093/hmg/8.9.1631)
- Jones, A. C. et al., 1999. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clinical Chemistry 45 (8), pp.1133-1140.
Erthyglau
- Clark, J. et al. 2016. The biological effects upon the cardiovascular system consequent to exposure to particulates of less than 500 nm in size. Biomarkers 21 (1), pp.1-47. (10.3109/1354750X.2015.1118540)
- Elvidge, T. et al. 2013. Feasibility of using biomarkers in blood serum as markers of effect following exposure of the lungs to particulate matter air pollution [review]. Journal of Environmental Science and Health, Part C 31 (1), pp.1-44. (10.1080/10590501.2013.763575)
- Matthews, I. P. et al. 2013. Maximal extent of translocation of single-walled carbon nanotubes from lung airways of the rat. Environmental Toxicology and Pharmacology 35 (3), pp.461-464. (10.1016/j.etap.2013.02.002)
- Van Woerden, H. C. et al. 2013. Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infectious Diseases 13 69. (10.1186/1471-2334-13-69)
- Deschepper, M. P. et al. 2012. Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes. Brain Research Bulletin 88 (2-3), pp.210-222. (10.1016/j.brainresbull.2011.01.012)
- Hoogendoorn, B. et al. 2012. Gene and protein responses of human lung tissue explants exposed to ambient particulate matter of different sizes. Inhalation Toxicology 24 (14), pp.966-975. (10.3109/08958378.2012.742600)
- Price, H. D. et al. 2010. Airborne particles in Swansea, UK: their collection and characterization. Journal of Toxicology and Environmental Health-Part A 73 (5-6), pp.355-367. (10.1080/15287390903442652)
- Buckland, P. R. et al. 2005. Strong bias in the location of functional promoter polymorphisms. Human Mutation 26 (3), pp.214-223. (10.1002/humu.20207)
- Buckland, P. R. et al. 2005. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain. American Journal of Psychiatry 162 (3), pp.613-615. (10.1176/appi.ajp.162.3.613)
- Buckland, P. R. et al. 2004. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Acta Biochimica et Biophysica 1690 (3), pp.238-249.
- Hoogendoorn, B. et al. 2004. Functional analysis of polymorphisms in the promoter regions of genes on 22q11. Human Mutation 24 (1), pp.35-42. (10.1002/humu.20061)
- Guy, C. et al. 2004. Promoter polymorphisms in glutathione-S-transferase genes affect transcription. Pharmacogenetics 14 (1), pp.45-51. (10.1097/00008571-200401000-00005)
- Hoogendoorn, B. et al. 2003. Functional analysis of human promoter polymorphisms. Human Molecular Genetics 12 (18), pp.2249-2254. (10.1093/hmg/ddg246)
- Buckland, P. R. et al. 2003. A high proportion of chromosome 21 promoter polymorphisms influence transcriptional activity. Gene Expression 11 (5), pp.233-239. (10.3727/000000003783992225)
- Smith, S. K. et al. 2003. Lack of functional promoter polymorphisms in genes involved in glutamate neurotransmission. Psychiatric Genetics 13 (4), pp.193-199. (10.1097/00041444-200312000-00001)
- Norton, N. et al., 2002. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Human Genetics 110 (5), pp.471-478. (10.1007/s00439-002-0706-6)
- Anney, R. et al. 2002. Characterisation, mutation detection, and association analysis of alternative promoters and 5' UTRs of the human dopamine D3 receptor gene in schizophrenia. Molecular psychiatry 7 (5), pp.493-502. (10.1038/sj.mp.4001003)
- Coleman, S. L. et al. 2002. Experimental analysis of the annotation of promoters in the public database. Human Molecular Genetics 11 (16), pp.1817-1821. (10.1093/hmg/11.16.1817)
- Williams, N. M. et al. 2002. Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor. Molecular Psychiatry 7 (5), pp.508-514. (10.1038/sj.mp.4001030)
- Coleman, S. L. et al. 2002. Streamlined approach to functional analysis of promoter-region polymorphisms. Biotechniques 33 (2), pp.412-418.
- Abraham, R. et al., 2001. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Human Genetics 109 (6), pp.646-652. (10.1007/s00439-001-0614-1)
- Bowen, T. et al. 2001. Mutation screening of the KCNN3 gene reveals a rare frameshift mutation [Letter]. Molecular Psychiatry 6 (3), pp.259-260. (10.1038/sj.mp.4000128)
- Austin, J. et al., 2000. The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia. Molecular Psychiatry 5 (5), pp.552-557. (10.1038/sj.mp.4000761)
- Austin, J. et al., 2000. Association analysis of the proneurotensin gene and bipolar disorder. Psychiatric Genetics 10 (1), pp.51-54. (10.1097/00041444-200010010-00009)
- Austin, J. et al., 2000. Comparative sequencing of the proneurotensin gene and association studies in schizophrenia. Molecular Psychiatry 5 (2), pp.208-212. (10.1038/sj.mp.4000693)
- Hoogendoorn, B. et al. 2000. Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools. Human Genetics 107 (5), pp.488-493. (10.1007/s004390000397)
- Jones, A. C. et al., 2000. Application and evaluation of denaturing HPLC for molecular genetic analysis in tuberous sclerosis. Human Genetics 106 (6), pp.663-668. (10.1007/s004390000316)
- Speight, G. et al., 2000. Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder. Molecular Psychiatry 5 (3), pp.327-331. (10.1038/sj.mp.4000717)
- Hoogendoorn, B. et al. 1999. Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Human Genetics 104 (1), pp.89-93. (10.1007/s004390050915)
- Jacobsen, N. J. et al., 1999. ATP2A2 mutations in Darier's disease and their relationship to neuropsychiatric phenotypes. Human Molecular Genetics 8 (9), pp.1631-1636. (10.1093/hmg/8.9.1631)
- Jones, A. C. et al., 1999. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clinical Chemistry 45 (8), pp.1133-1140.
Ymchwil
Bywgraffiad
Addysg a chymwysterau
1998: PhD (Bioleg Moleciwlaidd) BBSRC/Prifysgol Hertfortshire, UK.
1994: BSc ac MSc (Patholeg Planhigion/Nematoleg) Prifysgol Amaethyddol Wageningen, Wageningen, Yr Iseldiroedd.
1984: BSc (Sŵoleg a Microbioleg / Patholeg Planhigion) Prifysgol Natal, Pietermaritzburg, De Affrica.
Anrhydeddau a dyfarniadau
Sefydliad Bill a Melinda Gates $ 100,000. Datblygu offeryn pwynt gofal ar gyfer diagnosis cyflym o niwmonia. Rhwng mis Tachwedd 2015 a mis Mai 2017. Bastiaan Hoogendoorn, Colin Powell, Clive Gregory (Ysgol Meddygaeth), Jenna Bowen, Chris Allender (Ysgol Fferylliaeth).
Efrydiaeth PhD 2015, "Prosiect i bennu dichonoldeb mesur llwyth bacteriol mewn anadl allwthiol o blant â niwmonia ac empyema gan ddefnyddio prawf pwynt gofal newydd." Yn dechrau 5 Hydref 2015. CU Ysgol Meddygaeth / Sefydliad Gofal Sylfaenol ac Iechyd y Cyhoedd PhD Studenthip. Goruchwyliwr: Bastiaan Hoogendoorn; Cyd-oruchwylwyr: Colin Powell, Clive Gregory, Chris Allender.
Sefydliad Bill a Melinda Gates $ 100,000. Datblygu dyfais patsh micro-nodwydd hunan-weinyddol ar gyfer samplu cyfaint bach o waed ar draws y boblogaeth. O 1 Mai 2012 am 24 mis. Yr Athro I Matthews, Dr J Gallacher, Dr C Gregory, Dr B Hoogendoorn (Ysgol Meddygaeth) Yr Athro D Barrow (Ysgol Peirianneg) a Dr C Allender (Ysgol Fferylliaeth).
MRC/NERC project. £143,065. Astudiaeth archwiliadol sy'n ymchwilio i nodweddion ffisigo-gemegol sylfaenol gronynnau aer amgylchynol anadladwy sy'n gyfrifol am ddadreoleiddio genynnau ysgyfeiniol a phroteinau cysylltiedig. O fis Gorffennaf 2007 am flwyddyn. Yr Athro I Matthews, Dr B Hoogendoorm, Dr J Gregory, Dr K Berube, Dr T Jones.
Prosiect Ymchwil Cymdeithas Alzheimer. £131,314. Parhad dadansoddiad proteome cymharol o'r model llygoden clefyd Alzheimer trawsgenig Tg2576. O fis Hydref 2005 am 2 flynedd. B Hoogendoorn, PI; AL Jones, MJ Owen, MC O'Donovan, Cyd-PI.
Efrydiaeth PhD o UWCM a ddyfarnwyd i Ms Mia Deschepper (B Hoogendoorn ac AL Jones). Dadansoddiad proteomic o fodelau llygoden o glefyd Huntington. O fis Hydref 2003 am 3 blynedd.
Cymrodoriaeth Ymchwil Cymdeithas Alzheimer. £173,314. Dadansoddiad proteome cymharol o'r model llygoden clefyd Alzheimer trawsgenig Tg2576. O fis Hydref 2002 am 3 blynedd.
Aelodaethau proffesiynol
Cymrawd yr Academi Addysg Uwch